» Articles » PMID: 36140353

Zebrafish: A Useful Animal Model for the Characterization of Drug-Loaded Polymeric NPs

Overview
Journal Biomedicines
Date 2022 Sep 23
PMID 36140353
Authors
Affiliations
Soon will be listed here.
Abstract

The use of zebrafish (ZF) embryos as an in vivo model is increasingly attractive thanks to different features that include easy handling, transparency, and the absence of adaptive immunity until 4-6 weeks. These factors allow the development of xenografts that can be easily analyzed through fluorescence techniques. In this work, ZF were exploited to characterize the efficiency of drug-loaded polymeric NPs as a therapeutical approach for B-cell malignancies. Fluorescent probes, fluorescent transgenic lines of ZF, or their combination allowed to deeply examine biodistribution, elimination, and therapeutic efficacy. In particular, the fluorescent signal of nanoparticles (NPs) was exploited to investigate the in vivo distribution, while the colocalization between the fluorescence in macrophages and NPs allows following the elimination pathway of these polymeric NPs. Xenotransplanted human B-cells (Nalm-6) developed a reproducible model useful for demonstrating drug delivery by polymeric NPs loaded with doxorubicin and, as a consequence, the arrest of tumor growth and the reduction in tumor burden. ZF proved to be a versatile model, able to rapidly provide answers in the development of animal models and in the characterization of the activity and the efficacy of drug delivery systems.

Citing Articles

DNA-loaded targeted nanoparticles as a safe platform to produce exogenous proteins in tumor B cells.

Grimaldi M, Bozzer S, Sjostrom D, Andersson L, Mollnes T, Nilsson P Front Immunol. 2025; 15:1509322.

PMID: 39911576 PMC: 11794205. DOI: 10.3389/fimmu.2024.1509322.


Stealth-Engineered Albumin-Coated Nanoparticles for Targeted Therapy: Effective Drug Delivery and Tumor Suppression in Xenograft-Zebrafish Model.

Bozzer S, Grimaldi M, De Maso L, Manfredi M, Toffoli G, Dal Bo M Int J Nanomedicine. 2024; 19:13267-13286.

PMID: 39679253 PMC: 11645898. DOI: 10.2147/IJN.S476241.


Biological Features of Nanoparticles: Protein Corona Formation and Interaction with the Immune System.

Panico S, Capolla S, Bozzer S, Toffoli G, Dal Bo M, Macor P Pharmaceutics. 2022; 14(12).

PMID: 36559099 PMC: 9781747. DOI: 10.3390/pharmaceutics14122605.

References
1.
Inaba H, Mullighan C . Pediatric acute lymphoblastic leukemia. Haematologica. 2020; 105(11):2524-2539. PMC: 7604619. DOI: 10.3324/haematol.2020.247031. View

2.
Letrado P, de Miguel I, Lamberto I, Diez-Martinez R, Oyarzabal J . Zebrafish: Speeding Up the Cancer Drug Discovery Process. Cancer Res. 2018; 78(21):6048-6058. DOI: 10.1158/0008-5472.CAN-18-1029. View

3.
Ghotra V, He S, de Bont H, van der Ent W, Spaink H, van de Water B . Automated whole animal bio-imaging assay for human cancer dissemination. PLoS One. 2012; 7(2):e31281. PMC: 3275564. DOI: 10.1371/journal.pone.0031281. View

4.
Warga R, Kane D, Ho R . Fate mapping embryonic blood in zebrafish: multi- and unipotential lineages are segregated at gastrulation. Dev Cell. 2009; 16(5):744-55. PMC: 2764372. DOI: 10.1016/j.devcel.2009.04.007. View

5.
Narezkina A, Narayan H, Zemljic-Harpf A . Molecular mechanisms of anthracycline cardiovascular toxicity. Clin Sci (Lond). 2021; 135(10):1311-1332. PMC: 10866014. DOI: 10.1042/CS20200301. View